New Research on Long-Covid Offers Hope for Patients Living with Condition
Dr Richard Webb
A new clinical study from Cardiff Metropolitan University – in collaboration with Cwm Taf Morgannwg University Health Board (CTM UHB) – has highlighted new biomedical insights into long-Covid.
The researchers say it could take existing studies one step closer to finding treatment for patients living with the condition.
Long-Covid is a new condition which can affect people who have previously had the Covid-19 virus. Symptoms can include heart disease, muscle and joint pain, extreme tiredness, coughing, shortness of breath and memory difficulties.
The clinical study – 'Seasonal variation in the associations between self-reported long-Covid symptoms and IL-6 signaling-related factors' – from Cardiff Met and CTM UHB included DNA and blood samples taken from 175 participants who had previously had the Covid-19 infection. The bloods taken measured levels of two proteins, 'Interleukin-6 (IL-6)' and 'Interleukin-6 Receptor (IL-6R)', while the DNA sample was used to detect which variant of IL-6R gene, known as 'IL-6R genotype', was present.
IL-6 and IL-6R are made by the immune system to fight infection. IL-6R is the receptor that IL-6 attaches to – like a key fitting into a lock. This connection allows IL-6 to send signals that trigger an immune response. Craig Greenstock
Craig Greenstock, 63, from Pontypridd took part in the study and was first admitted to hospital in December 2020 at the height of the pandemic after being diagnosed with CovidPneumonitis. He was previously fit and healthy.
Craig went on to spend the next nine weeks in hospital, initially placed on a ventilator within the intensive care unit before being moved to various wards.
He has since been diagnosed with long Covid and suffers with bouts of fatigue, breathlessness, brain fog, PTSD, night terrors and is being treated with three daily pumps for asthma related symptoms. A nodule was also discovered on Craig's lung following the infection.
Craig said:
'I can safely say that when I was first admitted to hospital and what then developed was the scariest time of my life, both physically and mentally.
'I was extremely unwell for some time, with my family being given 24 hours for my condition to improve. My symptoms following the virus have been so significant it has resulted in me having to retire from work.'
Participants were also asked to complete a questionnaire sharing their current long Covid symptoms at different times throughout the year to see if the change in seasons affected the condition, and to help get an accurate diagnosis.
The purpose of the study – which was funded through The Cwm Taf Morgannwg University Health Board Collaborative Research Fund – was to better understand how these IL-6-related factors contribute to the risk of long-Covid and possibly initiate future strategies for using them as biomarkers predictive of risk.
The results from the participants tested highlighted that long-Covid sufferers had elevated levels of IL-6 compared to those who had regained full health. The results also showed the risk of getting long-Covid appeared to be increased in patients with a particular type of IL-6R genotype, known as the 'AA' genotype.
Dr Richard Webb, a Principal Lecturer in Biomedical Sciences in the Centre for Cardiovascular Research, Innovation and Development (CURIAD) at Cardiff Metropolitan University is leading on the study.
He said:
'While interpretation is complicated by seasonal variations, the findings from the study point towards possible future use of IL-6 and IL-6R genotype as biomarkers predictive of long-Covid risk, which may bring advantages regarding the management and treatment of the illness.'
Dr Ceri Lynch is a Consultant in Anaesthetics and Intensive Care Medicine and Critical Care Research Lead at Cwm Taf Morgannwg University Health Board and has worked alongside Cardiff Met on the long-Covid symptoms study.
Dr Lynch said:
'This collaborative research between Cwm Taf Morgannwg and Cardiff Metropolitan University has shown some interesting and exciting findings with regard to the risk factors for developing long-Covid. We would like to continue this work, with the ultimate aim of identifying an effective drug treatment for the condition.'
Craig added:
'I was very fortunate to have a positive attitude to life and fairly healthy, so strong enough, physically and mentally, to be able to fight the virus and ongoing recovery.
'I would be prepared to try any medicine that could improve my standard of life back to anywhere near where it was before I fell ill.'
The team of researchers from Cardiff Met and CTM UHB will now look at how the findings from this study can be integrated into and support The Post-hospitalisation Covid-19 study (PHOSP-COVID) – which includes leading researchers and clinicians from across the UK working together to understand and improve long-term health outcomes for patients who have been in hospital with confirmed or suspected Covid-19.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
an hour ago
- Wales Online
Full list of Covid symptoms including three unusual ones as new variant reaches UK
Full list of Covid symptoms including three unusual ones as new variant reaches UK The new Covid variant has spread through several countries and now reached the UK The new strain was first detected in January (Image: Getty Images ) Brits are being warned to watch out for three unusual symptoms that could be a sign of a new Covid strain which has been detected in the UK. These symptoms are not typically associated with the virus and could lead to misdiagnosis. More than five years on from the start of the pandemic, Covid-19 continues to spread globally, with the virus mutating multiple times to produce new variants. The latest strain, NB.1.8.1, has already spread across several countries, with seven cases identified in Northern Ireland. First detected in January, this new strain is a sublineage of the Omicron variant, and the Health Protection Surveillance Centre reports that the number of Covid cases linked to it has jumped from 3.7 per cent to 33.3 per cent in just five weeks. The World Health Organisation has classified NB. 1.8.1 as a "variant under monitoring", due to its rapid global spread, with the strain now accounting for over 10 per cent of sequenced Covid infections worldwide, and dominating in China and Hong Kong. The new Covid variant, also detected in the US and Australia as well as holiday hotspots like Egypt, Thailand, and the Maldives, may be more transmissible than its predecessors, according to Dr Lara Herrero, research leader in virology at Griffith University. Three lesser-known symptoms While coughs, sore throats and loss of taste or smell are familiar signs of Covid, the NB. 1.8.1 strain might bring less recognised symptoms too. Stay informed on the latest health news by signing up to our newsletter here . Article continues below "Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants," Dr Herrero said, noting that some cases could exhibit gastrointestinal issues. As The Independent highlighted, these could include: Diarrhoea Constipation Nausea This could lead to confusion over whether someone is suffering from Covid or another illness. However, Dr Herrero explained that people may experience typical symptoms such as a sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion alongside the more unusual symptoms. Full list of symptoms a high temperature or shivering (chills) – a high temperature means you feel hot to touch on your chest or back (you do not need to measure your temperature) a new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours a loss or change to your sense of smell or taste shortness of breath feeling tired or exhausted an aching body a headache a sore throat a blocked or runny nose loss of appetite diarrhoea feeling sick or being sick If you think you have Covid, NHS advice is to minimise contact with others despite no legal self-isolation requirement, especially if you're displaying symptoms. Article continues below You can continue your usual activities when you feel better or do not have a high temperature. However, if you test positive, you should: Try to stay at home and avoid contact with other people for three days after the day the test was taken if you or your child is under 18 years old – children and young people tend to be infectious for less time than adults Try to stay at home and avoid contact with other people for five days after the day you took your test if you are 18 years old or over Avoid meeting people who are more likely to get seriously ill from infections, such as people with a weakened immune system, for 10 days after the day you took your test
Daily Mail
an hour ago
- Daily Mail
Shock Covid warning: Ultra-catchy 'Nimbus' variant could trigger summer wave amid 97 per cent infection surge
A new highly contagious Covid variant could spark a wave of infections this summer, scientists have warned. Dubbed 'Nimbus', the strain is descended from the already super virulent Omicron and has already triggered a surge in cases in China, Singapore and Hong Kong. Data from the UK Health Security Agency (UKHSA) also shows 13 cases of Nimbus, known scientifically as N.B.1.8.1, have already been detected in England. And 25 British samples of the strain have been submitted to an international Covid database since the end of March. However, both figures are likely an underestimation of how far the variant has spread given how testing has been massively reduced from the height of the pandemic. Other UKHSA data show the percentage of people testing positive for Covid has risen to its highest point this year, and is already 97 per cent higher than the level recorded in March. Now, British scientists have warned Nimbus could lead to a surge in Covid cases in a matter of weeks, and have urged the vulnerable to get vaccinated. They warn that many people's immunity to the virus, built up from previous infections and older jabs, has likely faded meaning they could be at higher risk of falling ill. Professor Lawrence Young, a virologist at Warwick University, said Nimbus had the potential to drive a surge in cases as the weather warms up and people become more sociable. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. He added lab studies suggest Nimbus can infect human cells more efficiently than previous strains, and that it may have increased ability to dodge the immune system, making it more likely to infect people. There is currently no evidence that the strain is more likely to cause severe illness or death in those it infects, compared to previous strains. However, infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Nimbus now accounts for 10.7 per cent of Covid infections worldwide, according to the World Health Organisation (WHO), compared to just 2.5 per cent a month prior. Last month the UN-body declared the strain a 'variant under monitoring'. This means that the WHO is tracking the virus, watching for signs it could pose a significant threat to the public which would promote it to a 'variant of concern'. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. Symptoms of Nimbus do not appear to differ from other Covid variants and include fatigue, fever, muscle ache and a sore throat. UKHSA data on Covid tests, which goes up to June 1, show 6.1 per cent of the people who were tested that week were positive for the virus, the highest figure for 2025 so far. This is a seven per cent rise from last week's figure and a 97 per cent increase from that recorded at the beginning of March. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents staff as well as people with a weakened immune system are eligible for a free Covid vaccine in Britain. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.
Leader Live
3 hours ago
- Leader Live
Covid booster warning as Covid NB.1.8.1 cases on the rise
The message comes after health experts also warned of a new COVID-19 variant, with cases of the strain are on the rise around the world. Covid NB.1.8.1 is a variation of the XDV.1.5.1 strain and was first detected back in January 2025. Ifti Khan, superintendent pharmacist at Well Pharmacy, urged those eligible to book as soon as possible and get the booster while it is still available. He said: 'Covid will most likely rise coming into the end of spring and into summer as people mix with friends and family more often. 'We know from previous boosters that they are effective in making sure that patients' symptoms are not as severe as they might have been without so I would urge patients to pop into their local Well Pharmacy store and get their jab. 'Patients have just over two weeks as the spring booster programme ends on June 17 so it would be my hope that those who can get a jab, opt to do so before enjoying socialising during summer.' Mr Khan warned that at this time of year, some people may believe they have hay fever as early symptoms of Covid include a runny or blocked nose or a sore throat. Covid tests can be obtained at any Well Pharmacy. The WHO has placed the Covid NB.1.8.1 "under monitoring" due to the rise in cases worldwide. It is one of six COVID-19 variants currently being monitored. The new 'Strategic and operational plan for coronavirus disease threat management: at a glance' sets out the global framework for supporting Member States in the sustained, integrated, evidence-based management of coronavirus disease threats, including #COVID19, MERS, and… However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation. The WHO added: "The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." COVID NB.1.8.1 has already been detected in 22 countries. These include the likes of Australia, China, Hong Kong, Thailand and the US, according to The Independent. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. Cases of the NB.1.8.1 variant have also been confirmed in Northern Ireland, Wales, and "popular British tourist hotspots", the news outlet added.
